Dietary sodium restriction is often overlooked, but can improve BP control, especially among patients treated with an agent to block the renin–angiotensin system.
In the presence of very high albuminuria, international guidelines consistently and strongly recommend the use of an angiotensin converting enzyme inhibitor or an angiotensin receptor blocker as the antihypertensive agent of first choice. Long-acting dihydropy ridine calcium channel blockers and diuretics are reasonable second- and third-line therapeutic options.
